Extended device longevity of 9 vs. 5 years for ICDs ; 7 vs. 4 years for CRT-Ds.
Device longevity has an important economic impact.
Extended longevity significantly decreases the cost of therapy.
From 9 to 14 years longevity
From 6 to 10 years longevity
Expected average savings per patient implanted over a 15-year time period.
Boriani G, Braunschweig F, Deharo JC et al. Impact of extending device longevity on the long-term costs of implantable cardioverter defibrillator therapy: a modelling study with a 15-year time horizon. Europace. 2013 Oct;15(10):1453-62.